Children hit hard as flu refuses to concede ground to Covid-19

As the world waits and watches to see what the coronavirus does next, the bad old flu is getting a second wind in the U.S.—and children may be bearing the brunt.

The CDC says 26 million Americans have come down with flu since the season arrived last fall. It’s driven around a quarter-million hospitalizations and claimed 14,000 lives.

And, as the Associated Press reports Feb. 14, the numbers are especially disturbing in the pediatric population. Some 92 flu-related deaths have already been reported in children—“a higher total at this point of the year than in any season in the past decade,” reporter Mike Stobbe writes. “And the hospitalization rates also are far higher than what’s been seen at this point.”

Curiously, it’s the usual focuses of worry—the elderly—who are faring relatively well versus the flu.

“In fact, the overall death and hospitalization rates this season are not high ‘because we haven’t seen the elderly as involved in this flu season,’ the CDC’s Lynnette Brammer tells the AP.

Read the whole thing:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup